netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 11: Eye - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
11.99.99.99  Expand sub section  Miscellaneous
Cytotoxic Drug Azathioprine tabs (ophthalmology indications - off-label)
View adult BNF View SPC online
Formulary
Amber 3

Refer to SE London immunomodulatory shared care guidance for list of indications (link below at end of BNF section)

 
   
Ciclosporin caps, oral liquid (ophthalmology indications, including off-label use)
View adult BNF View SPC online
Formulary
Amber 3

Refer to SE London immunomodulatory shared care guidance for list of indications (link below at end of BNF section)

 
   
Cytotoxic Drug Methotrexate tabs (ophthalmology indications - off-label)
View adult BNF View SPC online
Formulary
Amber 3

Refer to SE London immunomodulatory shared care guidance for list of indications (link below at end of BNF section)

 
   
Mycophenolate mofetil tabs, caps, suspension (ophthalmology indications - off-label)
View adult BNF View SPC online
Formulary
Amber 3

Refer to SE London immunomodulatory shared care guidance for list of indications (link below at end of BNF section)

 
   
Adalimumab injection (uveitis)
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
BlueTeq

Approved for treating non-infectious uveitis as per NICE TA460

 
Link  NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis
   
Rituximab injection (neuromyelitis optica - off-label)
View adult BNF View SPC online
Formulary
Red
High Cost Medicine

Approved off-label indication:

Neuromyelitis optica as per NHS England service specification D04/S(HSS)/b

Category B* form required

First 2 courses given and funded by NHS England commissioned centres. If ongoing care is needed it may be given locally via local funding

Biosimilar products available, to be prescribed by brand name.

Contact pharmacy department for advice on brand for routine prescribing if unsure

 
Link  NHSE D04/S(HSS)/b: Neuromyelitis optica service (adults and children)
   
Acetylcysteine eye drops 10%
Unlicensed Drug Unlicensed Dry eye associated with increased mucous production 
   
Acetylcysteine preservative-free eye drops 5%
Unlicensed Drug Unlicensed Dry eye associated with increased mucous production 
   
Healonid GV injection
Unlicensed Drug Unlicensed

Corneal endothelial protection

 
   
Miraflow cleaning solution
Unlicensed Drug Unlicensed Contact lens cleaner 
   
Cytotoxic Drug Mitomycin topical eye solution 0.02% and 0.04%
Unlicensed Drug Unlicensed
Red

Prevention of scar tissue formation following glaucoma filtering surgery

 
   
Mydricaine ampoule No. 2
Unlicensed Drug Unlicensed
Red

ADULT USE ONLY

Contains:

  • Procaine hydrochloride
  • Atropine sulphate
  • Adrenaline Mydriatic given by subconjunctival injection prior to vitroretinal surgery
 
   
Perfluoro-N-Octane injection
Unlicensed Drug Unlicensed Aid to ocular surgery 
   
Potassium ascorbate eye drops
Unlicensed Drug Unlicensed Chemical burns to eye 
   
Sodium citrate eye drops 10.11%
Unlicensed Drug Unlicensed
Red
Chemical burns to eye 
   
EDTA eye drops 0.37% (Disodium edetate - for chemical burns to eye)
Unlicensed Drug Unlicensed
Red

Approved for the following indication:

  • Chelating agent for chemical burns to eye
 
   
EDTA eye drops 0.37% (Disodium edetate - chelating agent in calcific band keratopathy)
Unlicensed Drug Unlicensed
Red

Approved for the following indication:

  • Chelating agent in calcific band keratopathy
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary